US Stock MarketDetailed Quotes

MNMD Mind Medicine

Watchlist

8.9106
-0.1594-1.76%

Trading May 16 09:58 ET

640.43MMarket Cap-3041P/E (TTM)

Mind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-24.51%-16.6M

-28.37%-64.37M

-60.04%-20.56M

-78.83%-16.63M

8.47%-13.85M

-3.61%-13.33M

-9.42%-50.14M

-64.04%-12.85M

44.60%-9.3M

-35.41%-15.13M

Net income from continuing operations

-119.22%-54.4M

-68.55%-95.73M

-386.72%-23.86M

-8.72%-17.92M

-71.79%-29.13M

-34.49%-24.82M

38.95%-56.8M

70.87%-4.9M

4.13%-16.49M

62.53%-16.96M

Operating gains losses

544.30%33.41M

196.64%6.27M

132.56%2.6M

---2.68M

--1.17M

--5.19M

---6.49M

---7.99M

----

Depreciation and amortization

-33.38%527K

-0.57%3.16M

0.00%790K

0.13%791K

-3.66%790K

1.41%791K

21.56%3.18M

0.25%790K

0.13%790K

5.26%820K

Other non cash items

435.71%75K

265.12%157K

123.08%29K

669.23%100K

--14K

--43K

--13K

----

Change In working capital

-138.82%-677K

266.08%6.28M

-77.88%-3.8M

-289.98%-1.14M

390.52%9.47M

72.16%1.74M

-301.17%-3.78M

-155.21%-2.13M

113.37%599K

-1,138.22%-3.26M

-Change in prepaid assets

-48.51%468K

115.00%39K

26.75%-1.54M

-56.94%558K

128.35%108K

-1.41%909K

87.98%-260K

32.14%-2.1M

48.79%1.3M

-148.35%-381K

-Change in payables and accrued expense

-230.92%-1.19M

397.05%7.34M

-922.98%-1.93M

-1,440.00%-1.08M

438.70%9.44M

503.97%912K

-147.54%-2.47M

-97.10%235K

98.69%-70K

-488.19%-2.79M

-Change in other current assets

266.67%66K

128.33%51K

95.00%-9K

--25K

--17K

--18K

---180K

--0

-Change in other current liabilities

82.11%-17K

-32.41%-1.15M

-244.57%-317K

-2.55%-643K

-6.59%-97K

-58.33%-95K

---870K

---92K

---627K

---91K

Cash from discontinued investing activities

Operating cash flow

-24.51%-16.6M

-28.37%-64.37M

-60.04%-20.56M

-78.83%-16.63M

8.47%-13.85M

-3.61%-13.33M

-9.42%-50.14M

-64.04%-12.85M

44.60%-9.3M

-35.41%-15.13M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

28,930.36%169.25M

-63.00%21.85M

523.32%2.59M

-70.11%17.4M

115.93%1.27M

451.20%583K

-40.25%59.05M

227.56%416K

6,998.90%58.21M

-92.52%590K

Net issuance payments of debt

---128K

--14.16M

---42K

----

--0

----

Net common stock issuance

30,085.93%175.98M

-82.20%7.53M

254.25%2.59M

-92.58%3.09M

--1.27M

--583K

-48.37%42.3M

--730K

1,039,275.00%41.57M

--0

Proceeds from stock option exercised by employees

--2.17M

-99.13%163K

--49K

-99.36%114K

--0

10.42%18.66M

--0

2,063.83%17.83M

-92.69%590K

Net other financing activities

---8.77M

----

---1.91M

---314K

---1.19M

--0

Cash from discontinued financing activities

Financing cash flow

28,930.36%169.25M

-63.00%21.85M

523.32%2.59M

-70.11%17.4M

115.93%1.27M

451.20%583K

-40.25%59.05M

227.56%416K

6,998.90%58.21M

-92.52%590K

Net cash flow

Beginning cash position

-29.86%99.7M

6.44%142.14M

-23.83%117.7M

10.55%116.9M

7.42%129.41M

6.44%142.14M

66.73%133.54M

5.89%154.52M

-32.69%105.74M

-24.72%120.47M

Current changes in cash

1,297.43%152.65M

-577.08%-42.52M

-44.53%-17.97M

-98.42%772K

13.52%-12.57M

2.18%-12.75M

-83.09%8.91M

-63.74%-12.43M

405.92%48.91M

-334.07%-14.54M

Effect of exchange rate changes

-240.00%-21K

125.57%79K

-144.64%-25K

123.53%32K

129.38%57K

142.86%15K

-141.64%-309K

101.17%56K

-102.83%-136K

-147.78%-194K

End cash Position

94.99%252.33M

-29.86%99.7M

-23.83%117.7M

10.55%116.9M

7.42%129.41M

6.44%142.14M

5.89%154.52M

-32.69%105.74M

Free cash flow

-24.51%-16.6M

-28.37%-64.37M

-60.04%-20.56M

-78.83%-16.63M

8.47%-13.85M

-3.61%-13.33M

-9.42%-50.14M

-64.04%-12.85M

44.60%-9.3M

-35.41%-15.13M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-24.51%-16.6M	-28.37%-64.37M	-60.04%-20.56M	-78.83%-16.63M	8.47%-13.85M	-3.61%-13.33M	-9.42%-50.14M	-64.04%-12.85M	44.60%-9.3M	-35.41%-15.13M
Net income from continuing operations	-119.22%-54.4M	-68.55%-95.73M	-386.72%-23.86M	-8.72%-17.92M	-71.79%-29.13M	-34.49%-24.82M	38.95%-56.8M	70.87%-4.9M	4.13%-16.49M	62.53%-16.96M
Operating gains losses	544.30%33.41M	196.64%6.27M	132.56%2.6M	---2.68M	--1.17M	--5.19M	---6.49M	---7.99M	----	----
Depreciation and amortization	-33.38%527K	-0.57%3.16M	0.00%790K	0.13%791K	-3.66%790K	1.41%791K	21.56%3.18M	0.25%790K	0.13%790K	5.26%820K
Other non cash items	435.71%75K	265.12%157K	123.08%29K	669.23%100K	--14K	--14K	--43K	--13K	--13K	----
Change In working capital	-138.82%-677K	266.08%6.28M	-77.88%-3.8M	-289.98%-1.14M	390.52%9.47M	72.16%1.74M	-301.17%-3.78M	-155.21%-2.13M	113.37%599K	-1,138.22%-3.26M
-Change in prepaid assets	-48.51%468K	115.00%39K	26.75%-1.54M	-56.94%558K	128.35%108K	-1.41%909K	87.98%-260K	32.14%-2.1M	48.79%1.3M	-148.35%-381K
-Change in payables and accrued expense	-230.92%-1.19M	397.05%7.34M	-922.98%-1.93M	-1,440.00%-1.08M	438.70%9.44M	503.97%912K	-147.54%-2.47M	-97.10%235K	98.69%-70K	-488.19%-2.79M
-Change in other current assets	266.67%66K	128.33%51K	95.00%-9K	--25K	--17K	--18K	---180K	---180K	--0	--0
-Change in other current liabilities	82.11%-17K	-32.41%-1.15M	-244.57%-317K	-2.55%-643K	-6.59%-97K	-58.33%-95K	---870K	---92K	---627K	---91K
Cash from discontinued investing activities
Operating cash flow	-24.51%-16.6M	-28.37%-64.37M	-60.04%-20.56M	-78.83%-16.63M	8.47%-13.85M	-3.61%-13.33M	-9.42%-50.14M	-64.04%-12.85M	44.60%-9.3M	-35.41%-15.13M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	28,930.36%169.25M	-63.00%21.85M	523.32%2.59M	-70.11%17.4M	115.93%1.27M	451.20%583K	-40.25%59.05M	227.56%416K	6,998.90%58.21M	-92.52%590K
Net issuance payments of debt	---128K	--14.16M	---42K	----	----	--0	--0	--0	----	----
Net common stock issuance	30,085.93%175.98M	-82.20%7.53M	254.25%2.59M	-92.58%3.09M	--1.27M	--583K	-48.37%42.3M	--730K	1,039,275.00%41.57M	--0
Proceeds from stock option exercised by employees	--2.17M	-99.13%163K	--49K	-99.36%114K	--0	--0	10.42%18.66M	--0	2,063.83%17.83M	-92.69%590K
Net other financing activities	---8.77M	----	----	----	----	----	---1.91M	---314K	---1.19M	--0
Cash from discontinued financing activities
Financing cash flow	28,930.36%169.25M	-63.00%21.85M	523.32%2.59M	-70.11%17.4M	115.93%1.27M	451.20%583K	-40.25%59.05M	227.56%416K	6,998.90%58.21M	-92.52%590K
Net cash flow
Beginning cash position	-29.86%99.7M	6.44%142.14M	-23.83%117.7M	10.55%116.9M	7.42%129.41M	6.44%142.14M	66.73%133.54M	5.89%154.52M	-32.69%105.74M	-24.72%120.47M
Current changes in cash	1,297.43%152.65M	-577.08%-42.52M	-44.53%-17.97M	-98.42%772K	13.52%-12.57M	2.18%-12.75M	-83.09%8.91M	-63.74%-12.43M	405.92%48.91M	-334.07%-14.54M
Effect of exchange rate changes	-240.00%-21K	125.57%79K	-144.64%-25K	123.53%32K	129.38%57K	142.86%15K	-141.64%-309K	101.17%56K	-102.83%-136K	-147.78%-194K
End cash Position	94.99%252.33M	-29.86%99.7M	-29.86%99.7M	-23.83%117.7M	10.55%116.9M	7.42%129.41M	6.44%142.14M	6.44%142.14M	5.89%154.52M	-32.69%105.74M
Free cash flow	-24.51%-16.6M	-28.37%-64.37M	-60.04%-20.56M	-78.83%-16.63M	8.47%-13.85M	-3.61%-13.33M	-9.42%-50.14M	-64.04%-12.85M	44.60%-9.3M	-35.41%-15.13M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall